Updates in the Diagnosis and Management of Autoimmune Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: closed (10 September 2024) | Viewed by 1552
Special Issue Editors
Interests: Takayasu arteritis; ANCA vasculitis; systemic vasculitis; cardiovascular risk in rheumatic diseases; systemic sclerosis; systematic reviews; meta-analyses
Special Issues, Collections and Topics in MDPI journals
Interests: systemic sclerosis; targeted treatments; interstitial lung disease; digital ulcers; calcinosis; pulmonary arterial hypertension; autoantibodies; progression; disease outcomes; Takayasu arteritis; giant cell arteritis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Autoimmune diseases are an important cause of morbidity and early mortality in the general population. Autoimmune diseases affect individuals from childhood to older age groups. These diseases may be organ-specific (such as myasthenia gravis or autoimmune thyroiditis) or systemic (such as rheumatoid arthritis, spondyloarthritis, systemic sclerosis, systemic lupus erythematosus, Sjogren’s syndrome, inflammatory myositis, or systemic vasculitis). The diagnosis and management of autoimmune diseases are areas of active evolution. Through clinical studies of large cohorts, various prognostic markers of autoimmune diseases are increasingly being identified. The same also holds true with regard to molecular biomarkers of autoimmune disease diagnosis and prognosis, whether these biomarkers are genomic, proteomic, or metabolomic. The possibility of expanding the knowledge of specific molecular targets has also led to the approval of newer drugs for the management of autoimmune diseases or the inclusion of new clinical indications for already approved targeted therapies. Moreover, preclinical research on autoimmune diseases and the mechanisms of autoimmunity over the past few years has been extremely productive, with many ground-breaking steps. This Special Issue focuses on updates in the diagnosis, pathogenesis, prognosis, and treatment of autoimmune diseases, particularly on systemic autoimmune diseases. Original articles and review articles on these aspects of autoimmune diseases are welcomed. All the articles shall undergo peer review as per the standard protocols of the journal and be accepted only after successful peer review.
Dr. Durga Prasanna Misra
Dr. Corrado Campochiaro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmune diseases
- rheumatoid arthritis
- spondyloarthritis
- systemic sclerosis
- Sjogren’s syndrome
- vasculitis
- inflammatory myositis
- juvenile idiopathic arthritis
- systemic lupus erythematosus
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.